Literature DB >> 25080405

Hormonal changes and increased anxiety-like behavior in a perimenopause-animal model induced by 4-vinylcyclohexene diepoxide (VCD) in female rats.

F M C V Reis1, N Pestana-Oliveira2, C M Leite3, F B Lima4, M L Brandão1, F G Graeff5, C M Del-Ben6, J A Anselmo-Franci7.   

Abstract

Perimenopause, a transition period that precedes menopause, is characterized by neuroendocrine, metabolic and behavioral changes, and is associated with increased vulnerability to affective disorders. The decrease in ovarian follicles during perimenopause contributes to a dynamic and complex hormonal milieu that is not yet well characterized. In rodents, 4-vinylcyclohexene diepoxide (VCD) induces a gradual depletion of ovarian follicles, modeling the transition to menopause in women. This study was aimed to investigate, in VCD-treated rats, the hormonal status and the behavior in the elevated plus-maze (EPM), a widely used test to assess anxiety-like behavior. From the postnatal day 28, rats were treated with VCD or vehicle for 15 days. At 80±5 days after the beginning of treatment the experiments were performed at proestrus and diestrus. In the first experiment rats were decapitated, ovary was collected and blood samples were taken for estradiol, progesterone, follicle stimulant hormone (FSH), testosterone, dihydrotestosterone (DHT) and corticosterone measurements. In the second experiment, rats were subjected to the EPM for 5 min, and behavioral categories recorded. Administration of VCD induced follicular depletion as well as an increase of the number of atretic follicles demonstrating the treatment efficacy. The transitional follicular depletion was accompanied by lower progesterone, testosterone and DHT with no changes in the FSH, estradiol and corticosterone plasma levels. On the EPM, rats showed decreased open arm exploration and increased risk assessment behavior, indicating increased anxiety. These findings show that administration of VCD to induce ovarian failure results in endocrine and anxiety-related changes that are similar to the symptoms exhibited by women during menopause transition. Thus, this model seems to be promising in the study of perimenopause-related changes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; DHT; Estradiol; FSH; Follicular depletion; Glucocorticoids; Perimenopause; Progesterone; Testosterone

Mesh:

Substances:

Year:  2014        PMID: 25080405     DOI: 10.1016/j.psyneuen.2014.06.019

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  8 in total

Review 1.  Modeling menopause: The utility of rodents in translational behavioral endocrinology research.

Authors:  Stephanie V Koebele; Heather A Bimonte-Nelson
Journal:  Maturitas       Date:  2016-02-03       Impact factor: 4.342

2.  Resveratrol ameliorates estrogen deficiency-induced depression- and anxiety-like behaviors and hippocampal inflammation in mice.

Authors:  Tianyao Liu; Yuanyuan Ma; Ruiyu Zhang; Hongyu Zhong; Lian Wang; Jinghui Zhao; Ling Yang; Xiaotang Fan
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

3.  Effects of Estrogen Therapy on the Serotonergic System in an Animal Model of Perimenopause Induced by 4-Vinylcyclohexen Diepoxide (VCD).

Authors:  Nayara Pestana-Oliveira; Bruna Kalil; Cristiane Mota Leite; Ruither Oliveira Gomes Carolino; Lucas Kniess Debarba; Lucila Leico Kagohara Elias; José Antunes-Rodrigues; Janete A Anselmo-Franci
Journal:  eNeuro       Date:  2018-01-22

4.  Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study.

Authors:  Fatemeh Seyyedi; Mahmoud Rafiean Kopaei; Sepideh Miraj
Journal:  Electron Physician       Date:  2016-11-25

5.  Prefrontal cortex-dependent innate behaviors are altered by selective knockdown of Gad1 in neuropeptide Y interneurons.

Authors:  Katelynn M Corder; Mariana A Cortes; Aundrea F Bartley; Samantha A Lear; Farah D Lubin; Lynn E Dobrunz
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

6.  Assessment of Psychological Status and Oxidative Stress in Postmenopausal Women: A Cross-Sectional Study.

Authors:  Manju Chandankhede; Madhur Gupta; Smita Pakhmode
Journal:  J Menopausal Med       Date:  2021-12

7.  Development of a Chemical Reproductive Aging Model in Female Rats.

Authors:  Nayara Pestana-Oliveira; Ruither O G Carolino; Bruna Kalil-Cutti; Cristiane M Leite; Litamara C Dalpogeto; Bruna Balbino De Paula; John P Collister; Janete Anselmo-Franci
Journal:  Bio Protoc       Date:  2021-04-20

8.  Endocrine profile of the VCD-induced perimenopausal model rat.

Authors:  Ruither O G Carolino; Paulo T Barros; Bruna Kalil; Janete Anselmo-Franci
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.